Abstract:AbstractAim:To investigate the effect of simvastatin on the cardiac contractile function and the alteration of gene and protein expression of the sarcoplasmic calcium regulatory proteins, including sarcoplasmic reticulum Ca2+-ATPase (SERCA), phospholamban (PLB), and ryanodine receptor 2 (RyR2) in rat hearts.Methods:Langendorff-perfused rat hearts were subjected to 60-min perfusion with different concentrations of simvastatin (1, 3, 10, 30, or 100 μmol/L), and the parameters of cardiac function such as left ventricular developed pressure (LVDP), +dp/dtmax, and -dp/dtmax were determined. The cultured neonatal rat ventricular cardiomyocytes were incubated with simvastatin (1, 3, 10, 30, and 100 μmol/L) for 1 h or 24 h. The levels of SERCA, PLB, and RyR2 expression were measured by reverse transcription-polymerase chain reaction and Western blot. Cytotoxic effect of simvastatin on ventricular cardiomyocytes was assessed by the MTT colorimetric assay.Results:LVDP, +dp/dtmax, and -dp/dtmax of hearts were increased significantly after treatment with simvastatin 3, 10, and 30 μmol/L. In simvastatin-treated isolated hearts, the levels of mRNA expression of SERCA and RyR2 were elevated compared with the control (P<0.05), while the mRNA expression of PLB did not change. After the cultured neonatal rat ventricular cardiomyocytes were incubated with 3, 10, 30, and 100 μmol/L simvastatin for 1 h, SERCA and RyR2 mRNA expressions of cardiomyocytes rose, but there was no alteration in protein expressions. However, with the elongation of simvastatin treatment to 24 h, the protein expression of SERCA and RyR2 were also elevated. Additionally, simvastatin (1-30 μmol/L) had no influence on cell viability of cultured cardiac myocytes, but simvastatin 100 μmol/L inhibited the cell viability.Conclusion:Simvastatin improved cardiac performance accompanied by the elevation of SERCA and RyR2 gene and protein expression.

Suppressive Effects of Lovastatin on PARP-1 Activation and Expression in Cultured Rat Cardiac Fibroblast

Effects of Simvastatin on Cardiac Performance and Expression of Sarco-Plasmic Reticular Calcium Regulatory Proteins in Rat Heart

Beneficial effect of rosuvastatin on cardiac dysfunction is associated with alterations in calcium-regulatory proteins.

Sbudies on the Effect of Parthenolide on the Proliferation of Rat Vascular Smooth Muscle Cells and the Mechanism

Effects of lovastatin on expression of hypoxia inducible factor 1 alpha on U937 cell induced by oxidized low density lipoprotein

Effects of Atorvastatin on Myocardium Expression of Peroxisome Proliferator-Activated Receptors in Spontaneously Hypertensive Rats

Effect of carvedilol on expression of Smad proteins mediated by AngⅡ in cardiac fibroblasts

Effects of Lovastatin on Proliferation and Extracellular Matrix Secretion in Cultured Rat Mesangial Cells

Effect of AngiotensinⅡ on the poly(ADP-ribose) polymerase-1 activity and expression of cardiomyocytes

Inhibition of poly(ADP-ribose)polymerase prevented angiotensin Ⅱ induced abnormal gene expression in cultured cardiomyocyte

Lovastatin Changes Activities of Lactate Dehydrogenase A and B Genes in Rat Myocardial Cells.

Lovastatin in Regulation of Mesangial Cell Proliferation and Activity of TGF-β1 Promoter in Rats

PARP-1 suppresses adiponectin expression through poly(ADP-ribosyl)ation of PPAR gamma in cardiac fibroblasts.

PARP-1 Suppresses Adiponectin Expression Through Poly(adp-Ribosyl)ation of PPARγ in Cardiac Fibroblasts

The regulation of lovastatin on transforming growth factorβ1 and interleukin-6 in cardiac myocytes

Inhibition of PARP Prevents Angiotensin II-induced Aortic Fibrosis in Rats

Regulation of Lovastatin on a Key Inflammation-Related Microrna in Myocardial Cells.

Effect of poly(ADP·ribose) polymerase-1 on the expression of associated inflammatory cytokines in rats' myocardium after myocardial infarction

PARP-2 knockdown protects cardiomyocytes from hypertrophy via activation of SIRT1.

PARP-1 Inhibition Attenuates Cardiac Fibrosis Induced by Myocardial Infarction Through Regulating Autophagy.

Lovastatin Upregulates Microrna-29B to Reduce Oxidative Stress in Rats with Multiple Cardiovascular Risk Factors